Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Colorectal Neoplasms

Free Subscription 05.01.2026 1 Am J Epidemiol 1 Ann Oncol 6 Ann Surg Oncol 7 Anticancer Res 5 BMC Cancer 5 BMC Gastroenterol 1 Br J Cancer 1 Cancer 1 Cancer Lett 1 Clin Cancer Res 4 Dis Colon Rectum 1 Gastroenterology 3 Gut 1 Int J Cancer 1 J Nucl Med 1 J Surg Oncol 1 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Epidemiol

1. SANTIAGO-RODRIGUEZ EJ, White JS, Bailey ZD, Allen IE, et al
   Residential segregation and late-stage colorectal cancer in the United States: a population-based study of 1.2 million adults.
   Am J Epidemiol. 2025 Dec 24:kwaf285. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. CIARDIELLO D, Martini G, Bielo LB, Pietrantonio F, et al
   Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.
   Ann Oncol. 2025 Dec 22:S0923-7534(25)06334-3. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. VALDES N, Diaz L, Torrico P, Crespo I, et al
   ASO Visual Abstract: Targeted Preoperative Nutritional Support Within an Enhanced Recovery After Surgery Program for Malnourished Colorectal Cancer Patients: Postoperative Outcomes Comparable to Well-Nourished Patients in a Prospective Single-Center C
   Ann Surg Oncol. 2025 Dec 29. doi: 10.1245/s10434-025-18932.
   PubMed        
   
   
4. BAO W, Wang T, Wang Y, Chen L, et al
   Causal Inference and Prognostic Modeling in Colorectal Cancer through Integration of Computational Pathology and Mendelian Randomization.
   Ann Surg Oncol. 2025 Dec 26. doi: 10.1245/s10434-025-18901.
   PubMed         Abstract available
   
   
5. BAO W
   ASO Author Reflections: Bridging the Gut-Immune Axis and Histology: A Novel Computational Approach to Colorectal Cancer.
   Ann Surg Oncol. 2025 Dec 26. doi: 10.1245/s10434-025-18972.
   PubMed        
   
   
6. HANEVELT J, Rademaker E, Zamaray B, Brohet RM, et al
   Depth of Tumor Invasion (T-Stage) is Not Associated with Survival or Recurrence Rates in Patients Undergoing Surgery for pT1 and pT2 Colon Cancer.
   Ann Surg Oncol. 2025 Dec 24. doi: 10.1245/s10434-025-18735.
   PubMed         Abstract available
   
   
7. HANEVELT J, Rademaker E, Zamaray B, Brohet RM, et al
   ASO Visual Abstract: Depth of Tumor Invasion (T-stage) is not Associated with Survival or Recurrence Rates in Patients Undergoing Surgery for pT1 and pT2 Colon Cancer.
   Ann Surg Oncol. 2025 Dec 23. doi: 10.1245/s10434-025-18896.
   PubMed        
   
   
8. WU Y, Xie Y, Lin J, Cui J, et al
   ASO Visual Abstract: CD103-Positive Tumor-Infiltrating Lymphocytes Predict a Favorable Prognosis in Colorectal Cancer with Liver Metastasis.
   Ann Surg Oncol. 2025 Dec 22. doi: 10.1245/s10434-025-18201.
   PubMed        
   
   

   
   Anticancer Res

9. OHTAKI KI, Takeuchi R, Iwayama K, Chuma M, et al
   Evaluation of Regorafenib-induced Pancreatic Enzyme Elevation in Metastatic Colorectal Cancer Treatment.
   Anticancer Res. 2026;46:359-369.
   PubMed         Abstract available
   
   
10. NODA K, Tominaga T, Hashimoto S, Yamashita M, et al
    Effect of Pathological Response After Neoadjuvant Chemotherapy on Long-term Outcomes in Locally Advanced Colorectal Cancer: A Japanese Multicenter Study.
    Anticancer Res. 2026;46:327-336.
    PubMed         Abstract available
    
    
11. KATAYAMA H, Noda K, Tominaga T, Hashimoto S, et al
    Effect of the Endoscopic Surgical Skill Qualification System for Colorectal Cancer Surgery With Multivisceral Resection on Long-term Outcomes: Japanese Multicenter Analysis.
    Anticancer Res. 2026;46:457-465.
    PubMed         Abstract available
    
    
12. MATSUBARA D, Soga K, Fujita Y, Ochi F, et al
    Oncological Outcomes of Laparoscopic Surgery With Stent Bridge in Stage II-III Obstructive Colorectal Cancer.
    Anticancer Res. 2026;46:347-357.
    PubMed         Abstract available
    
    
13. KIM BH, Lee J, Lee D, Kim K, et al
    Immune Microenvironment Signatures Predict Response and Survival in Rectal Cancer Patients After Neoadjuvant Chemoradiation.
    Anticancer Res. 2026;46:123-134.
    PubMed         Abstract available
    
    
14. NARIHIRO S, Kitaguchi D, Ryu S, Fukuda M, et al
    Short-term Outcomes of Robotic-assisted Versus Laparoscopic Right Hemicolectomy for Right-sided Colon Cancer: A Retrospective Study.
    Anticancer Res. 2026;46:493-501.
    PubMed         Abstract available
    
    
15. KOSUGE T, Mazaki J, Kasahara K, Osakabe H, et al
    Prediction of the Clinicopathological Prognosis of Colon Cancer After Radical Resection Using Artificial Intelligence "TabNet".
    Anticancer Res. 2026;46:467-474.
    PubMed         Abstract available
    
    

    
    BMC Cancer

16. HU F, Shi X, Cheng X, Yao H, et al
    Methylmalonic acid modulates neutrophil function to promote tumor progression in colorectal cancer.
    BMC Cancer. 2025 Dec 22. doi: 10.1186/s12885-025-15489.
    PubMed        
    
    
17. WANG D, Zhao Z, Zhao W, Chen G, et al
    Surgery versus stereotactic body radiotherapy for oligometastatic colorectal cancer: a prospective cohort study with propensity score matching.
    BMC Cancer. 2025 Dec 22. doi: 10.1186/s12885-025-15448.
    PubMed         Abstract available
    
    
18. LI G, Wang D, Chen G
    Single-cell RNA sequencing defines prognostic subtypes and identifies AIF1L as a therapeutic target in colorectal cancer.
    BMC Cancer. 2025;25:1885.
    PubMed         Abstract available
    
    
19. MAHJOURIAN MM, Zeinalabedini M, Hanjani NA, Azadbakht L, et al
    Association of dietary carbohydrate intake, glycemic index, and glycemic load with colorectal cancer risk in adults: a systematic review and dose-response meta-analysis of prospective cohort studies.
    BMC Cancer. 2025 Dec 27. doi: 10.1186/s12885-025-15466.
    PubMed        
    
    
20. HUO J, Chen H, Zhang X, Sun D, et al
    Histone acetyltransferase KAT6A contributes to colon cancer malignant progression by inhibiting ferroptosis.
    BMC Cancer. 2025 Dec 27. doi: 10.1186/s12885-025-15368.
    PubMed         Abstract available
    
    

    
    BMC Gastroenterol

21. KESGIN YM, Bulut S, Abdullayev S, Suskun B, et al
    Effect of stent placement on short term survival of left sided obstructive colorectal cancer: comparison of bridge-to-surgery versus emergency surgery approaches.
    BMC Gastroenterol. 2025;25:880.
    PubMed         Abstract available
    
    
22. ZHANG Y, Chen Y, Guo W, Guo Y, et al
    Inhibition of autotaxin sensitizes colon cancer to radiation by suppressing LPAR2-AKT survival signaling.
    BMC Gastroenterol. 2025 Dec 26. doi: 10.1186/s12876-025-04578.
    PubMed        
    
    
23. BUCKMAN TA, Sakyi SA, Yorke J, Laryea J, et al
    Prognostic factors and survival outcomes in colorectal cancer: insights from a Ghanaian cohort.
    BMC Gastroenterol. 2025;25:876.
    PubMed         Abstract available
    
    
24. TABESH E, Rahimi F, Soheilipour M, Tavakoli-Moghadam N, et al
    Evaluating quality indicators in colorectal cancer screening via fecal immunochemical tests: a five-year study from a developing country.
    BMC Gastroenterol. 2025 Dec 30. doi: 10.1186/s12876-025-04527.
    PubMed        
    
    
25. AL-ZIHAYMEE RMM, Mohammadnejad J, Narmani A, Jafar H, et al
    Sodium butyrate entrapped chitosan-PAMAM for suppression of colorectal cancer cells.
    BMC Gastroenterol. 2025;25:875.
    PubMed         Abstract available
    
    

    
    Br J Cancer

26. LASKAR RS, Murphy N, Ferrari P, Brennan P, et al
    A prospective investigation of early-onset colorectal cancer risk factors-pooled analysis of three large-scale European cohorts.
    Br J Cancer. 2025 Dec 20. doi: 10.1038/s41416-025-03303.
    PubMed         Abstract available
    
    

    
    Cancer

27. ALATISE OI, Owoade IA, Fayenuwo OJ, Lawal NOO, et al
    Customized early detection of colorectal cancer in Nigeria identifies advanced adenomas and early-stage disease.
    Cancer. 2026;132:e70156.
    PubMed         Abstract available
    
    

    
    Cancer Lett

28. FRANK M, Ghirardello G, Howie JM, Braun N, et al
    Spatial organization of stromal subtypes stratifies colorectal cancer patients and predicts clinical outcomes.
    Cancer Lett. 2025;639:218228.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

29. MANCA P, Paoli M, Galardi F, Morano F, et al
    CtDNA detection with low-pass whole genome bisulfite sequencing in RAS wild-type metastatic colorectal cancer: an exploratory objective of the VALENTINO trial.
    Clin Cancer Res. 2025 Dec 22. doi: 10.1158/1078-0432.CCR-25-2773.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

30. FERNANDEZ L, Azevedo J, Santiago I, Castillo M, et al
    A Significant Proportion of Stage II and III Rectal Cancers, Selected By Precision Magnetic Resonance, Can Safely Be Managed By Upfront Total Mesorectal Excision Surgery Without Neoadjuvant Therapy.
    Dis Colon Rectum. 2025 Oct 24. doi: 10.1097/DCR.0000000000003987.
    PubMed         Abstract available
    
    
31. GARRETT C, Brown KGM, Solomon MJ, Sutton PA, et al
    Conventional Versus High-Complexity Total Pelvic Exenteration for Locally Advanced and Locally Recurrent Rectal Cancer: An International Multicenter Study.
    Dis Colon Rectum. 2026;69:34-41.
    PubMed         Abstract available
    
    
32. AGGARWAL M, Aggarwal A, Goel S, Goyal S, et al
    Prognostic Factors and Long-term Outcomes in Patients With Colorectal Peritoneal Metastases Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Cohort Study From a Tertiary Care Center in India.
    Dis Colon Rectum. 2026;69:42-52.
    PubMed         Abstract available
    
    
33. MAO Y, Zheng Z, Huang L, Chen P, et al
    Stoma-Free Intersphincteric Resection in Low Rectal Cancer Without Radiotherapy: A Prospective Cohort Study on Safety and Recovery.
    Dis Colon Rectum. 2026;69:24-33.
    PubMed         Abstract available
    
    

    
    Gastroenterology

34. DE FRUTOS ROSA D, Alonso Sebastian I, Barquero Declara D, Badia Closa J, et al
    A Randomized Trial of Endoscopic Submucosal Dissection vs Transanal Minimally Invasive Surgery in Early Rectal Neoplasms: DSETAMIS-2018 Study.
    Gastroenterology. 2026;170:161-173.
    PubMed         Abstract available
    
    

    
    Gut

35. 
    Correction: RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer.
    Gut. 2025 Dec 25:gutjnl-2020-320652corr1. doi: 10.1136/gutjnl-2020-320652.
    PubMed        
    
    
36. TAN H, Huang L, Wang J, Huang H, et al
    Parasutterella excrementihominis exacerbates experimental colitis and colitis-associated colorectal cancer via pathogenic NETosis activation.
    Gut. 2025 Dec 25:gutjnl-2025-335887. doi: 10.1136/gutjnl-2025-335887.
    PubMed         Abstract available
    
    
37. DU M, Wang X, Hang D, Wang F, et al
    Metabolomic pattern of ultraprocessed food intake and its association with colorectal cancer risk.
    Gut. 2025 Dec 24:gutjnl-2025-335618. doi: 10.1136/gutjnl-2025-335618.
    PubMed         Abstract available
    
    

    
    Int J Cancer

38. ALI E, Ye W, Pavlov S, Cervenkova L, et al
    Distribution and prognostic value of T-cells in primary colorectal cancer and adjacent non-tumor mucosa in stage IV versus stage I-III patients.
    Int J Cancer. 2025 Dec 30. doi: 10.1002/ijc.70319.
    PubMed         Abstract available
    
    

    
    J Nucl Med

39. RONG Z, Liu H, Teng X, Chen L, et al
    Construction and Evaluation of Guanylyl Cyclase C-Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer.
    J Nucl Med. 2025 Dec 30:jnumed.125.270400. doi: 10.2967/jnumed.125.270400.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

40. HAM-KARIM HA
    Evaluation of Circulating miR-155, miR-221, miR-34a, and miR-143 for Monitoring Tumor Clearance After Surgery in Colorectal Cancer.
    J Surg Oncol. 2025 Dec 22. doi: 10.1002/jso.70166.
    PubMed         Abstract available
    
    

    
    Oncogene

41. WANG H, Ge L, Li J, Zhong K, et al
    NAT10 triggers colorectal cancer progression via promoting PPAN-regulated DNA damage repair.
    Oncogene. 2025 Dec 27. doi: 10.1038/s41388-025-03661.
    PubMed         Abstract available
    
    

    
    PLoS One

42. ALYABSI MS, Alqarni AH, Almutairi AF, Alhalafi MS, et al
    Comparative effectiveness of open versus laparoscopic resection in patients with locally advanced colon cancer: Inverse probability of treatment weighting approach.
    PLoS One. 2025;20:e0338741.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.